Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Finland

Marie Skłodowska-Curie Action · Running

NOVEL Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being

Coordinator
Ita-Suomen Yliopisto, Finland
Runs
1 December 2024 to 30 November 2029
Status
Running
EU funding
€2.0m
Total cost
—
Partners
37 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101179145

What the project is doing

In the project's own words, from its summary on CORDIS.

The NOVEL Postdoctoral Programme pioneers in merging diverse socio-cultural and scientific expertise to forge new brain health solutions, energizing regional, national and global development. It integrates neuroscience, data science, innovation management, and social and legal studies across four synergetic research areas: Prevention and Care, Methods and Data, Innovation and Society, Ethics and Wellbeing. This initiative thrives on cooperation with companies, health organizations, patient groups, and universities, offering a rich training blend through compulsory non-academic secondments, mentoring, and dynamic summer schools.

Targeting under-represented and minority scientists across different disciplines, NOVEL encourages applicants to work on their research projects within an inclusive community-based platform, ensuring equal opportunities. The merit-based selection process is transparent, conducted by external international assessors. NOVEL’s training goals are multifaceted: nurturing research excellence and inclusivity, fostering broad intersectoral networks, embracing Open Science, and aspiring to be a global benchmark in brain health research training.

The training is structured into three pillars: enhancing disciplinary skills, developing transferable competencies in innovation, management, leadership, and ethics, and boosting active parnerships and stakeholder engagement. Mandatory and optional secondments with NOVEL partners underscore its comprehensive intersectoral approach. The programme promises attractive employment conditions, including 36-month contracts, competitive compensation, strong local support systems, and an inspiring environment for research and collaboration.

Each fellow receives guidance from multiple supervisors and a mentor, facilitating both conventional and innovative career trajectories, positioning NOVEL at the forefront of research training in brain health.

Who is involved

OrganisationCityCountryRole
Ita-Suomen YliopistoKuopioFinlandCoordinator
Icometrix NVLeuvenBelgiumAssociatedpartner
Universiteit AntwerpenAntwerpenBelgiumAssociatedpartner
Royal Institution for the Advancement of Learning Mcgill UniversityMontrealCanadaAssociatedpartner
Eberhard Karls Universitaet TuebingenTuebingenGermanyAssociatedpartner
Technische Universitaet MuenchenMuenchenGermanyAssociatedpartner
CoNurse OÜTallinnEstoniaAssociatedpartner
Institut De Recerca De L'hospital De La Santa Creu I Sant Pau FundacionBarcelonaSpainAssociatedpartner
Audicin OyHelsinkiFinlandAssociatedpartner
Brain Relief Academy OyKuopioFinlandAssociatedpartner
Charles River Discovery Research Services Finland OyKuopioFinlandAssociatedpartner
Combinostics OyTampereFinlandAssociatedpartner
Epilepsialiitto ry, Epilepsiförbundet rfHelsinkiFinlandAssociatedpartner
Finnadvance OyHelsinkiFinlandAssociatedpartner
Kuopio Health Co-OpKuopioFinlandAssociatedpartner
Liikehäiriösairauksien liitto ryTurkuFinlandAssociatedpartner
Marginum OyTampereFinlandAssociatedpartner
MuistiliittoHelsinkiFinlandAssociatedpartner
Novartis Finland OyEspooFinlandAssociatedpartner
Orion OyjEspooFinlandAssociatedpartner
Pohjois-Savon HyvinvointialueKuopioFinlandAssociatedpartner
Samfundet Folkhalsan I Svenska Finland RfHelsinkiFinlandAssociatedpartner
Suomen Punainen RistiHelsinkiFinlandAssociatedpartner
StellarQTurkuFinlandAssociatedpartner
Suomen Aivosäätiö SrHelsinkiFinlandAssociatedpartner
Tampereen Korkeakoulusaatio SrTampereFinlandAssociatedpartner
Turun YliopistoTurkuFinlandAssociatedpartner
Wellpro Impact Solutions OyJyväskyläFinlandAssociatedpartner
Biotalentum Tudasfejleszto KftGoedoelloHungaryAssociatedpartner
Universitetet I OsloOsloNorwayAssociatedpartner
Bioarctic ABStockholmSwedenAssociatedpartner
Basic Genomics ABSolnaSwedenAssociatedpartner
Karolinska InstitutetStockholmSwedenAssociatedpartner
Esya Ltd.LondonUnited KingdomAssociatedpartner
The University of BirminghamBirminghamUnited KingdomAssociatedpartner
University College LondonLondonUnited KingdomAssociatedpartner
Regents of University of MinnesotaMinneapolis MnUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI